Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04773171
Status:
COMPLETED
Last Update Posted:
2023-03-06
First Post:
2021-02-08
Brief Title:
Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia
Sponsor:
The Hong Kong Polytechnic University
Organization:
The Hong Kong Polytechnic University
Study Overview
Official Title:
Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective To determine the efficacy of computer-assisted cognitive remediation CACR in patients with chronic schizophrenia in the community settings
Study Design Single-blinded prospective pre-testpost-test randomized controlled trial RCT will be conducted in 2 groups of participants that receiving training in community settings Treatment groups will attend individualized CACR programme using CogniPlus while control group will continue attend conventional treatment as usual TAU Assessment on the means difference in assessing functions will be done after the study
Samples 80 patients with stable and chronic schizophrenia will be recruited from the community using a sampling frame of selected diagnosis and homogeneity
Expected Findings Find out the training effects of selected CACR on EF and daily functioning in patients with schizophrenia
Study Design Single-blinded prospective pre-testpost-test randomized controlled trial RCT will be conducted in 2 groups of participants that receiving training in community settings Treatment groups will attend individualized CACR programme using CogniPlus while control group will continue attend conventional treatment as usual TAU Assessment on the means difference in assessing functions will be done after the study
Samples 80 patients with stable and chronic schizophrenia will be recruited from the community using a sampling frame of selected diagnosis and homogeneity
Expected Findings Find out the training effects of selected CACR on EF and daily functioning in patients with schizophrenia
Detailed Description:
Schizophrenia is one of the most serious and disabling mental disorders Prevalence of schizophrenia is about 1 worldwide The related dysfunctions have great impact and burden to the concerned person and to the society With increasing use of CR programmes in helping the patients to resume their capability in community living the clinical outcome was not fully established especially on specific cognitive domains such as executive function EF The present study aims at evaluating the efficacy of CACR on developing EF and improving daily functioning The result will provide information for therapists future clinical decisions for patients best reintegration into the societies This also helps decrease the burden of family society in the long run
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None